The collaboration is a celebration of, and will debut at, a Nov. 13 international friendly slated for Red Bull Arena in Harrison when USA faces off against Germany.

The event was one of two winning entries in a competition sponsored and funded by the Newark Police Foundation as a way to prompt the city's Police Department to improve its outreach to the city's youth.

The milestone for The Residences at Raritan Town Square marks the final phase of a mixed-use redevelopment project at the 60-acre former site of the Flemington Fairgrounds and Speedway.

After nearly seven years, Kathleen Boozang will step down Jan. 1, 2023. Until then, she'll work on the transition with interim leader, John Kip Cornwell.

The Dufry-owned company – which has more than 1,000 stores in airports, commuter hubs and tourist destinations across North America – will exclusively operate new standalone travel retail stores for the eyewear seller in the U.S. and Canada.

According to Executive Director Robinson Holloway, “Art Fair 14C was created as an answer to the question of how to help people in the visual arts make a living."

Michael Hays has "a strong track record of expansion, coupled with a reputation for building a world-class packaging manufacturing group,” said current President Maurice Barakat, who will take on the roles of executive chairman and CEO.

JLL Capital Markets arranged the construction funding on behalf of Hillsborough-based developer Country Classics.

Cushman & Wakefield arranged the sale of the 30,327-square-foot retail South Jersey complex.

After seeing 70% growth in its business since 2019, the company invested $18 million to grow the facility by 100,000 square feet to keep up with increasing demand.

“We’ve established ourselves as a trusted leader in beef, but as we look to the future, we see ourselves as a leader in protein," President and CEO Jamie Schweid said. "Based on extensive territory mapping and other research to identify where our brand fits best, fresh breakfast pork sausage was one of the top performers."

Eleven months after its merger, the Montvale-based company – which develops drugs to treat infectious diseases such as COVID-19, as well as autoimmune and retinal diseases – announced its updated moniker: EOM Pharmaceutical Holdings Inc.